Atorvastatin in combination with inhaled beclometasone modulates inflammatory sputum mediators in smokers with asthma

Pulmonary Pharmacology and Therapeutics

Volumn 31, Issue , 2015, Pages 1-8

  Thomson, Neil C ^a   Charron, Catherine E ^b   Chaudhuri, Rekha ^a   Spears, Mark ^c   Ito, Kazuhiro ^b   McSharry, Charles ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c FORTH VALLEY ROYAL HOSPITAL   (United Kingdom)

Author keywords

Asthma; Inhaled steroids; Smokers; Sputum mediators; Statins

Indexed keywords

ATORVASTATIN; BECLOMETASONE; BETA INTERFERON; CD40 LIGAND; FIBROBLAST GROWTH FACTOR 2; FRACTALKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; NEUTROPHIL COLLAGENASE; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ANTIASTHMATIC AGENT; AUTACOID; CHEMOKINE; CYTOKINE;

ARTICLE; ASTHMA; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; EOSINOPHIL COUNT; FEMALE; HUMAN; MALE; NEUTROPHIL COUNT; PRIORITY JOURNAL; QUALITY OF LIFE; SPUTUM; ADULT; CONTROLLED STUDY; DRUG COMBINATION; FORCED EXPIRATORY VOLUME; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX;

ADMINISTRATION, INHALATION; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; ATORVASTATIN CALCIUM; BECLOMETHASONE; CHEMOKINES; CYTOKINES; DRUG THERAPY, COMBINATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SPUTUM;

EID: 84926313464     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2015.01.001     Document Type: Article

References (66)

1. Greenwood J., Steinman L., Zamvil S.S. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol 2006, 6(5):358-370.
2. Hothersall E., McSharry C., Thomson N.C. Potential therapeutic role for statins in respiratory disease. Thorax 2006, 61(8):729-734.
3. Yeganeh B., Wiechec E., Ande S., Sharma P., Moghadam A., Post M., et al. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease. Pharmacol Ther 2014, 143(1):87-110.
4. McKay A., Leung B.P., McInnes I.B., Thomson N.C., Liew F.Y. Anovel anti-inflammatory role of simvastatin in a murine model of allergic asthma. JImmunol 2004, 172(5):2903-2908.
5. Zeki A.A., Franzi L., Last J., Kenyon N.J. Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond. Am J Respir Crit Care Med 2009, 180(8):731-740.
6. Lee J.-H., Lee D.-S., Kim E.-K., Choe K.-H., Oh Y.-M., Shim T.-S., et al. Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs. Am J Respir Crit Care Med 2005, 172(8):987-993.
7. Davis B.B., Zeki A.A., Bratt J.M., Wang L., Filosto S., Walby W.F., et al. Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy. Eur Respir J 2013, 42(2):350-361.
8. Samson K., Minoguchi K., Tanaka A., Oda N., Yokoe T., Yamamoto Y., et al. Inhibitory effects of fluvastatin on cytokine and chemokine production by peripheral blood mononuclear cells in patients with allergic asthma. Clin Exp Allergy 2006, 36(4):475-482.
9. Maneechotesuwan K., Ekjiratrakul W., Kasetsinsombat K., Wongkajornsilp A., Barnes P.J. Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase. JAllergy Clin Immunol 2010, 126(4):754-762.
10. Chaudhuri R., Livingston E., McMahon A.D., Thomson L., Borland W., Thomson N.C. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003, 168(11):1308-1311.
11. Chalmers G.W., Macleod K.J., Little S.A., Thomson L.J., McSharry C.P., Thomson N.C. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002, 57(3):226-230.
12. Thomson N.C., Chaudhuri R., Heaney L.G., Bucknall C., Niven R.M., Brightling C.E., et al. Clinical outcomes and inflammatory biomarkers in current smokers and exsmokers with severe asthma. JAllergy Clin Immunol 2013, 131(4):1008-1016.
13. Thomson N., Chaudhuri R., Messow C.M., Spears M., MacNee W., Connell M., et al. Chronic cough and sputum production are associated with worse clinical outcomes in stable asthma. Resp Med 2013, 107(10):1501-1508.
14. Lazarus S.C., Chinchilli V.M., Rollings N.J., Boushey H.A., Cherniack R., Craig T.J., et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007, 175(8):783-790.
15. Polosa R., Thomson N.C. Smoking and asthma: dangerous liaisons. Eur Respir J 2013, 41(3):716-726.
16. Braganza G., Chaudhuri R., McSharry C., Weir C.J., Donnelly I., Jolly L., et al. Effects of short-term treatment with atorvastatin in smokers with asthma - a randomised controlled trial. BMC Pulm Med 2011, 11:16.
17. Global strategy for asthma management and prevention 2012, GINA report. http://www.ginasthma.com.
18. Pavord I., Pizzichini M., Pizzichini E., Hargreave F. The use of induced sputum to investigate airway inflammation. Thorax 1997, 52(6):498-501.
19. Juniper E.F., O'Byrne P.M., Guyatt G.H., Ferrie P.J., King D.R. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999, 14(4):902-907.
20. Juniper E.F., Guyatt G.H., Cox F.M., Ferrie P.J., King D.R. Development and validation of the mini asthma quality of life questionnaire. Eur Respir J 1999, 14(1):32-38.
21. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., et al. ATS/ERS task force standardisation of lung function testing: standardisation of spirometry. Eur Respir J 2005, 26(2):319-338.
22. Cockcroft D., Killian D., Mellon J., Hargreave F. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977, 7:235-243.
23. Barnes P.J. The cytokine network in asthma and chronic obstructive pulmonary disease. JClin Invest 2009, 118(11):3546-3556.
24. Barnes P.J. Pathophysiology of allergic inflammation. Immunol Rev 2011, 242(1):31-50.
25. Spears M., McSharry C., Chaudhuri R., Weir C.J., de Wet C., Thomson N.C. Smoking in asthma is associated with elevated levels of corticosteroid resistant sputum cytokines - an exploratory study. PLoS ONE 2013, 8(8):e71460.
26. Jarjour N.N., Busse W.W. Cytokines in bronchoalveolar lavage fluid of patients with nocturnal asthma. Am J Respir Crit Care Med 1995, 152(5 Pt 1):1474-1477.
27. Sousa A.R., Lane S.J., Nakhosteen J.A., Lee T.H., Poston R.N. Expression of interleukin-1 beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1ra) on asthmatic bronchial epithelium. Am J Respir Crit Care Med 1996, 154(4 Pt 1):1061-1066.
28. Simpson J.L., Phipps S., Baines K.J., Oreo K.M., Gunawardhana L., Gibson P.G. Elevated expression of the NLRP3 inflammasome in neutrophilic asthma. Eur Respir J 2014, 43(4):1067-1076.
29. Zanin V., Marcuzzi A., Kleiner G., Piscianz E., Monasta L., Zacchigna S., et al. Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both invitro and invivo. JCardiovasc Transl Res 2013, 6(6):981-988.
30. Di Stefano A., Caramori G., Barczyk A., Vicari C., Brun P., Zanini A., et al. Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. Thorax 2014, 69(6):516-524.
31. Rahman M., Abdelmotelb A. Study of atorvastatin in experimental allergic airway inflammation in mice. Int Immunopharmacol 2011, 11(8):1090-1094.
32. Huang C.-F., Peng H.-J., Wu C.-C., Lo W.-T., Shih Y.-L., Wu T.-C. Effect of oral administration with pravastatin and atorvastatin on airway hyperresponsiveness and allergic reactions in asthmatic mice. Ann Allergy Asthma Immunol 2013, 110(1):11-17.
33. Maneechotesuwan K., Kasetsinsombat K., Wamanuttajinda V., Wongkajornsilp A., Barnes P.J. Statins enhance the effects of corticosteroids on the balance between regulatory T cells and Th17 cells. Clin Exp Allergy 2013, 43(2):212-222.
34. Zeki A., Thai P., Kenyon N., Wu R. Differential effects of simvastatin on IL-13-induced cytokine gene expression in primary mouse tracheal epithelial cells. Resp Res 2012, 13(1):38.
35. Yilmaz A., Reiss C., Weng A., Cicha I., Stumpf C., Steinkasserer A., et al. Differential effects of statins on relevant functions of human monocyte-derived dendritic cells. JLeukoc Biol 2006, 79(3):529-538.
36. Cipollone F., Mezzetti A., Porreca E., Di Febbo C., Nutini M., Fazia M., et al. Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. Circulation 2002, 106(4):399-402.
37. Waehre T., Damås J.K., Gullestad L., Holm A.M., Pedersen T.R., Arnesen K.E., et al. Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease. JAm Coll Cardiol 2003, 41(9):1460-1467.
38. Wang Y., Chang H., Zou J., Jin X., Qi Z. The effect of atorvastatin on mRNA levels of inflammatory genes expression in human peripheral blood lymphocytes by DNA microarray. Biomed Pharmacother 2011, 65(2):118-122.
39. Lewis T.C., Henderson T.A., Carpenter A.R., Ramirez I.A., McHenry C.L., Goldsmith A.M., et al. Nasal cytokine responses to natural colds in asthmatic children. Clin Exp Allergy 2012, 42(12):1734-1744.
40. Cox G., Gauldie J., Jordana M. Bronchial epithelial cell-derived cytokines (G-CSF and GM-CSF promote the survical of peripheral blood neutrophils invitro. Am J Respir Cell Mol Biol 1992, 7(5):507-514.
41. Zineh I., Luo X., Welder G.J., DeBella A.E., Wessel T.R., Arant C.B., et al. Modulatory effects of atorvastatin on endothelial cell-derived chemokines, cytokines, and angiogenic factors. Pharmacotherapy 2006, 26(3):333-340.
42. Cundall M., Sun Y., Miranda C., Trudeau J.B., Barnes S., Wenzel S.E. Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids. JAllergy Clin Immunol 2003, 112(6):1064-1071.
43. Maher B.M., Dhonnchu T.N., Burke J.P., Soo A., Wood A.E., Watson R.W.G. Statins alter neutrophil migration by modulating cellular rho activity-a potential mechanism for statins-mediated pleiotropic effects?. JLeukoc Biol 2009, 85(1):186-193.
44. Barsante M.M., Roffê E., Yokoro C.M., Tafuri W.L., Souza D.G., Pinho V., et al. Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis. Eur J Pharmacol 2005, 516(3):282-289.
45. Atkinson J.J., Senior R.M. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 2003, 28(1):12-24.
46. Chaudhuri R., McSharry C., Brady J., Grierson C., Messow C.M., Spears M., et al. Low sputum MMP-9/TIMP ratio is associated with airway narrowing in smokers with asthma. Eur Respir J 2014, 44(4):895-904.
47. Sundararaj K.P., Samuvel D.J., Li Y., Nareika A., Slate E.H., Sanders J.J., et al. Simvastatin suppresses LPS-induced MMP-1 expression in U937 mononuclear cells by inhibiting protein isoprenylation-mediated ERK activation. JLeukoc Biol 2008, 84(4):1120-1129.
48. Liu H., Wang Z., Li Y., Li W., Chen Y. Simvastatin prevents proliferation and bone metastases of lung adenocarcinoma invitro and invivo. Neoplasma 2013, 60(3):240-246.
49. Turu M.M., Krupinski J., Catena E., Rosell A., Montaner J., Rubio F., et al. Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound. Atherosclerosis 2006, 187(1):161-169.
50. Bissonnette E., Madore A.-M., Chakir J., Laviolette M., Boulet L.-P., Hamid Q., et al. Fibroblast growth factor-2 is a sputum remodeling biomarker of severe asthma. JAsthma 2014, 51(2):119-126.
51. Folli C., Descalzi D., Bertolini S., Riccio A., Scordamaglia F., Gamalero C., et al. Effect of statins on fibroblasts from human nasal polyps and turbinates. Eur Ann Allergy Clin Immunol 2008, 40(3):84-89.
52. Firinci F., Karaman M., Cilaker-Micili S., Bagriyanik A., Uzuner N., Karaman O. The effect of atorvastatin on lung histopathology in a murine model of chronic asthma. Allergol Immunopathol Madr 2014, 42(4):355-361.
53. Ou X., Wen F., Uhal B., Feng Y., Huang X., Wang T., et al. Simvastatin attenuates experimental small airway remodelling in rats. Respirol 2009, 14(5):734-745.
54. Hardie W.D., Korfhagen T.R., Sartor M.A., Prestridge A., Medvedovic M., Le Cras T.D., et al. Genomic profile of matrix and vasculature remodeling in TGF-alpha induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2007, 37(3):309-321.
55. Ahmad T., Mabalirajan U., Sharma A., Aich J., Makhija L., Ghosh B., et al. Simvastatin improves epithelial dysfunction and airway hyperresponsiveness. Am J Respir Cell Mol Biol 2011, 44(4):531-539.
56. Zeki A.A., Bratt J.M., Rabowsky M., Last J.A., Kenyon N.J. Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling?. Transl Res 2010, 156(6):335-349.
57. Moore W.C., Hastie A.T., Li X., Li H., Busse W.W., Jarjour N.N., et al. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. JAllergy Clin Immunol 2014, 133(6):1557-1563.
58. Criner G.J., Connett J.E., Aaron S.D., Albert R.K., Bailey W.C., Casaburi R., et al. Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. NEng J Med 2014, 370:2201-2210.
59. Yuan C., Zhou L., Cheng J., Zhang J., Teng Y., Huang M., et al. Statins as potential therapeutic drug for asthma?. Respir Res 2012, 13(1):108.
60. Cowan D.C., Cowan J.O., Palmay R., Williamson A., Taylor D.R. Simvastatin in the treatment of asthma: lack of steroid-sparing effect. Thorax 2010, 65(10):891-896.
61. Hothersall E.J., Chaudhuri R., McSharry C., Donnelly I., Lafferty J., McMahon A.D., et al. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Thorax 2008, 63(12):1070-1075.
62. Menzies D., Nair A., Meldrum K.T., Fleming D., Barnes M., Lipworth B.J. Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma. JAllergy Clin Immunol 2007, 119(2):328-335.
63. Tse S.M., Li L., Butler M.G., Fung V., Kharbanda E.O., Larkin E.K., et al. Statin exposure is associated with decreased asthma-related emergency department visits and oral corticosteroid use. Am J Respir Crit Care Med 2013, 188(9):1076-1082.
64. Zeki A.A., Oldham J., Wilson M., Fortenko O., Goyal V., Last M., et al. Statin use and asthma control in patients with severe asthma. BMJ Open 2013, 3(8).
65. Lokhandwala T., West-Strum D., Banahan B.F., Bentley J.P., Yang Y. Do statins improve outcomes in patients with asthma on inhaled corticosteroid therapy? A retrospective cohort analysis. BMJ Open 2012, 2(3).
66. Tse S.M., Charland S.L., Stanek E., Herrera V., Goldfarb S., Litonjua A.A., et al. Statin use in asthmatics on inhaled corticosteroids is associated with decreased risk of emergency department visits. Curr Med Res Opin 2014, 30(4):685-693.